Troax Group (TROAX) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
30 Oct, 2025Executive summary
APAC delivered strong growth across all countries, while Europe and Americas lagged with only early signs of recovery in warehousing and continued weakness in automotive and construction.
Americas experienced a significant decline in order intake and profitability, with high customer hesitancy and operational issues.
Order intake and sales both declined by 7% year-over-year, impacted by a one-off factory transfer from Poland to Sweden.
Cost reduction initiatives are progressing as planned, with underlying reductions in sales and administrative costs.
Profitability was impacted by lower volumes, one-off costs from the closure of the Polish facility, and delayed price adjustments in North America.
Financial highlights
Q3 order intake was €62.2M, down 7% year-over-year, with a €3M negative impact from the factory transfer.
Net sales for Q3 were €64.2M, a 7% decrease year-over-year.
Adjusted EBITA was €10.3M (16.1% margin), down from €13.6M (19.7% margin) last year.
Adjusted EPS was €0.12, compared to €0.16 in Q3 last year.
Free operating cash flow reached €12.6M, with a cash conversion rate of 122%.
Outlook and guidance
New 2030 financial targets: at least €550M in sales (15% CAGR), adjusted EBITA margin above 20% over the cycle, net debt/EBITDA below 2.5x, and dividend payout of 40%-60%.
Management expects cost-saving and efficiency initiatives to improve profitability from 2026.
No specific Q4 sales growth commitment; 2030 targets are long-term ambitions.
Latest events from Troax Group
- Record order intake and sales, but profitability pressured by costs and higher net debt.TROAX
Q2 202617 Jul 2026 - Sales and profit fell due to weak demand and restructuring, but acquisitions support future recovery.TROAX
Q4 20259 Jul 2026 - Sales and profit fell 4% year-over-year, but APAC surged 94% and net debt/EBITDA is 0.9.TROAX
Q1 20258 Jul 2026 - Order intake and revenues rose 5–6%, but margins declined amid market headwinds.TROAX
Q2 202430 Jun 2026 - Order intake up 18% to EUR 82m on acquisitions, but organic sales and profit declined.TROAX
Q1 202621 Apr 2026 - Sales up 12% and EBITA margin 19.7%, with strong cash flow and global strategic investments.TROAX
Q3 202418 Jan 2026 - Q4 2024 order intake up 12%, EBITA margin 17.2%, strong cash flow, and stable dividend.TROAX
Q4 202423 Dec 2025 - Doubling sales to €550m by 2030, targeting 20% EBITA margin through regional growth and M&A.TROAX
CMD 202520 Nov 2025 - Order intake and sales declined, but cost savings and a strong balance sheet support future growth.TROAX
Q2 202518 Nov 2025